[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642313":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":35,"responsibleParty":64,"collaborators":10,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":69,"sex":75,"minAge":76,"maxAge":10,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":92,"whyStopped":10,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Group\u002FCohort Label: Gynecologic Multidisciplinary Tumor Board Physicians",null,"Physicians involved in clinical decision-making during ovarian and uterine cancer multidisciplinary tumor board meetings. Participants complete an online survey after each meeting; no intervention is administered.",[13],"Other: Online Survey Assessment of Tumor Board Group Dynamics",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Online Survey Assessment of Tumor Board Group Dynamics","Participants will complete an online survey after each ovarian and uterine cancer multidisciplinary tumor board meeting. The survey assesses group dynamics and decision-making processes, including team cohesion, minority dissent, team learning, task interdependence, collective information processing, team communication, individual information processing, and psychological safety. No clinical, pharmacological, diagnostic, surgical, radiation, behavioral, or therapeutic intervention will be administered.",[9],[20],"Questionnaire-Based Assessment",[22],{"name":23,"affiliation":5,"role":24},"Anna Fagotti","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Carmine Conte, Dr.","CONTACT","+393290275147","armine.conte@policlinicogemelli.it",{"name":32,"role":28,"phone":33,"phoneExt":10,"email":34},"Andrea Rosati, Dr.","+393385054943","andrea.rosati@policlinicogemelli.it",[36],{"facility":37,"status":10,"city":38,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Ginecologia Oncologica","Roma","00168","Italy","IT",{"type":43,"coordinates":44},"Point",[45,46],11.10642,44.99364,{"lat":46,"lon":45},[49,52,53,55,58,59,60,62],{"name":50,"role":28,"phone":29,"phoneExt":10,"email":51},"Carmine Conte, Dr","carmine.conte@policlinicogemelli.it",{"name":32,"role":28,"phone":33,"phoneExt":10,"email":34},{"name":54,"role":24,"phone":10,"phoneExt":10,"email":10},"Anna Fagotti, Prof.",{"name":56,"role":57,"phone":10,"phoneExt":10,"email":10},"Francesco Fanfani, Prof","SUB_INVESTIGATOR",{"name":27,"role":57,"phone":10,"phoneExt":10,"email":10},{"name":32,"role":57,"phone":10,"phoneExt":10,"email":10},{"name":61,"role":57,"phone":10,"phoneExt":10,"email":10},"Chiara Cantarini, Dr.",{"name":63,"role":57,"phone":10,"phoneExt":10,"email":10},"Massimo Criscione, Dr.",{"type":24,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"FAGOTTI ANNA","Prof.","100642313","evaluation-of-interactions-and-group-processes-in-multidisciplinary-tumor-boards-in-gynecologic-oncology-100642313",false,"NCT07645716","Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic Oncology","Group Dynamics Evaluation in ginecOlogic muLtidisciplinary Tumor boarDs","GOLD","Inclusion Criteria:\n\n* Physicians participating in the clinical decision-making process within ovarian and uterine cancer multidisciplinary tumor board meetings.\n* Participation in the full tumor board session.\n* Participation either in person or online.\n* Representation of at least one relevant specialty or role involved in the clinical decision-making process.\n\nExclusion Criteria:\n\n* Partial attendance at the ovarian and uterine cancer multidisciplinary tumor board session.\n* Trainees or other attendees not directly involved in the clinical decision-making process.\n* Physicians whose specialty contribution consists of occasional consultation for less than 50% of the study period.\n* Incomplete survey completion.\n* If more than one member represents the same specialty or role, participants with lower participation in the clinical decision-making process may be excluded.","ALL","18 Years",{"count":78,"type":79},400,"ESTIMATED","OBSERVATIONAL","Study Title Group Dynamics Evaluation in Gynecologic Multidisciplinary Tumor Boards - GOLD Study\n\nBackground and Rationale Multidisciplinary Tumor Boards are central to complex oncologic decision-making. In gynecologic oncology, clinical decisions often require the integration of knowledge from different specialties, including surgery, medical oncology, radiology, pathology, radiation oncology, and other relevant disciplines. These teams function not only as groups of specialists but also as collective decision-making systems, where communication, collaboration, information sharing, psychological safety, and group dynamics may influence the quality of clinical discussion and final recommendations.\n\nStudy Objective The GOLD Study aims to investigate the decision-making process and group dynamics within ovarian and uterine cancer Multidisciplinary Tumor Boards. The study will assess how communication patterns, collaboration, minority dissent, team cohesion, team learning, task interdependence, collective information processing, individual information processing, and psychological safety contribute to Tumor Board performance.\n\nStudy Design This is a single-center, prospective, longitudinal observational study involving physicians participating in ovarian and uterine cancer Multidisciplinary Tumor Boards, either in person or online.\n\nMethods At the end of each Tumor Board meeting, participating physicians will complete an online survey using Microsoft Forms. The questionnaire was developed within a scientific collaboration with the Department of Business and Management of LUISS Guido Carli University and includes validated measurement scales derived from the literature. In addition, data on team composition and participation will be collected for each meeting.\n\nStatistical Analysis Survey data and participation data will be analyzed using descriptive statistics, inferential methods, and social network analysis. Network measures such as density and centralization indices will be used to evaluate the structure of interactions and participation over time. Statistical analyses will be performed using Stata, R, and UCINET where appropriate.\n\nTarget Population and Sample Size The target population includes physicians involved in the clinical decision-making process during ovarian and uterine cancer Tumor Boards. A total of approximately 400 questionnaires is planned, based on the rule of thumb of at least 10 respondents per questionnaire variable.\n\nStudy Duration The expected study duration is six months.",[83,84],"Ovarian Neoplasms","Uterine Neoplasms",[83,84,86,87,88,89,90,91],"Multidisciplinary Tumor Board","Clinical Decision Making","Group Dynamics","Team Communication","Social Network Analysis","Surveys and Questionnaires","NOT_YET_RECRUITING","2026-06-09",{"date":95,"type":96},"2026-06-12","ACTUAL",{"date":98,"type":79},"2026-07-13",{"date":100,"type":79},"2027-03-31",{"name":5,"class":6},1]